TABLE 2.
Characteristics and Coexposures by Group
| SC Only (N= 107) |
Cannabis Only (N = 86) |
SC-Polydrug Use (N = 38) |
Cannabis- Polydrug Use (N = 117) |
|||||
|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | |
| Male sex | 87 | 81.3 | 57 | 66.3 | 33 | 86.8 | 79 | 67.5 |
| Female sex | 20 | 18.7 | 29 | 33.7 | 5 | 13.2 | 38 | 32.5 |
| Coexposure | ||||||||
| Analgesics | — | — | — | — | 4 | 10.53 | 11 | 9.40 |
| Anticoagulant | — | — | — | — | 1 | 2.63 | 0 | 0.00 |
| Anticholinergic | — | — | — | — | 5 | 13.16 | 17 | 14.53 |
| Anticonvulsant | — | — | — | — | 1 | 2.63 | 0 | 0.00 |
| Antidepressant | — | — | — | — | 5 | 13.16 | 8 | 6.84 |
| Antipsychotics | — | — | — | — | 5 | 13.16 | 5 | 4.27 |
| Cardiovascular | — | — | — | — | 0 | 0.00 | 1 | 0.85 |
| Cough and cold | — | — | — | — | 1 | 2.63 | 16 | 13.68 |
| Ethanol | — | — | — | — | 3 | 7.89 | 35 | 29.91 |
| Herbal supplement | — | — | — | — | 0 | 0.00 | 1 | 0.85 |
| Nicotine | — | — | — | — | 1 | 2.63 | 2 | 1.71 |
| Opioid | — | — | — | — | 1 | 2.63 | 17 | 14.53 |
| Psychoactive and/or hallucinogen | — | — | — | — | 4 | 10.53 | 15 | 12.82 |
| Sedative-hypnotic | — | — | — | — | 2 | 5.26 | 20 | 17.09 |
| Sympathomimeticsa | — | — | — | — | 17 | 44.74 | 35 | 29.91 |
| Unknown | — | — | — | — | 2 | 5.26 | 4 | 3.42 |
—
, not applicable.
a
Amphetamines, cocaine, synthetic cathinone, and 3,4-methylenedioxymethamphetamine.